UCB Announces U.S. FDA Approval of RYSTIGGO[®] (rozanolixizumab-noli) for the Treatment of Adults with Generalized Myasthenia Gravis What you need to know: This is a new therapy that is designed as a monoclonal antibody that binds to the neonatal Fc receptor (FcRN). The delivery of this therapy is subcutaneous injection – so it’s quicker and… Read more »
Posts Categorized: blog
June is Myasthenia Gravis Awareness Month
Myasthenia Gravis Awareness Month (1)
COVID and Myasthenia
COVID continues to be a concern if you are immunocompromised or have a weakened immune system because of a medical condition or a treatment for a condition. This is the case if you have myasthenia gravis, and are taking immuno-suppressant medication. The Centers for Disease Control continues to recommenf that those who are immunocompromised or… Read more »
7 Tips for Coping during the Holiday Season
By Maria Zepeda, NBC-HWC, and Julie Rowin, MD The Holiday Season is upon us, and this means a wonderful time for some and a difficult time for many. We are living through times of uncertainty and ambiguity which can feel overwhelming. Here are some suggestions on how to better cope with the challenges we… Read more »
Oct 25: Emerging Therapies Webinar
Register Now! Emerging Therapies for MG Tuesday, October 25, 2022; 6:30pm Central Speaker: Pritikanta Paul, MD, University of Illinois at Chicago After years of research and clinical trials, a number of new therapies for myasthenia gravis have arrived or will do so soon. Instead of suppressing a person’s entire immune system (as with drugs like… Read more »
